Price per procedure: $1.500
The PRP Facelift is not a traditional surgical facelift. It is a cutting-edge procedure that uses Hyaluronic Acid (HA) Fillers and the body’s own natural healing agents, Platelet Rich Plasma (PRP) and growth factors that are derived from your own blood. The platelet rich plasma contained in your blood contains growth factors which stimulate the production of collagen and tissue regeneration to deliver natural volume and a more youthful appearance.
How Does it Work?
The PRP Facelift is a procedure which utilizes a combination of HA Filler and PRP which is carefully injected into strategic areas of the face to reduce wrinkles, add youthful volume and improve the overall quality of the skin. The combination of HA Filler and PRP plump, fill out existing tissue, and facilitate the growth of new deep tissue including collagen and new fatty tissue.
What can I expect during the treatment?
A small amount of blood is drawn and processed in a special centrifuge. The processing separates the nutrient rich platelets from the blood. A topical anesthetic is applied to the face. An HA Filler is injected into the face to sculpt specific areas of the face. Then we inject the nutrient rich platelets and growth factors back into your skin to increase volume and rejuvenate your skin.
What are the results?
The PRP Facelift restores supple skin immediately with the addition of HA Filler. Skin renewal, rejuvenation and collagen stimulation continues for about 3 months after the procedure. Natural looking results can last up to 1 year or longer.
Is it Safe?
The PRP Facelift is very safe. This is a minimally invasive procedure and since we are using the PRP derived from your own blood there is no risk of allergic reaction. There may be some mild swelling and bruising but will subside in a few days. It is performed quickly, without surgery in the privacy of our office.
Are there contraindications?
Taking Warfarin; who have haemotological disorders or concurrent infections; who are being treated with Roaccutane; who have immunosuppression; undergoing chemotherapy; suffer from poorly controlled chronic medical conditions; and who are pregnant or breast-feeding.